Ann: Spenda announces strategic acquisition of Limepay, page-11

Let's look at this deal:

• Today's SP is $0.007
• first tranche of shares is issued at $0.0121, resulting in about 150m less shares being issued than if it was at the current SP.
• second tranche is tied to receipt of their R&D refund, likely to do with working cap requirements.
• tranches 3 & 4 are tied to revenue outcomes and have a floor price, so tranche 3 is issued at a price that is at least 2.5 times the current SP and tranche 4 is 3.2 times the current SP.
• if they don't produce the goods, then they don't get the shares.
• shares are escrowed so that there's not a race for the exit following completion.
• seems that Limepay has some technology that Spenda hasn't developed itself yet, so that may shorten the timeframe for Spenda to release products to the likes of CC, Cap & eBev and therefore bring forward revenue.

If they don't hit their revenue milestones, then SPX will have issued about 260m shares to acquire tech that they apparently need and therefore don't need to pay inhouse staff to build it, which we all know the staff costs are not cheap on a quarterly basis.